# Filing Detail

Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-25-058954
Filing Date
2025-03-20
Accepted
2025-03-20 16:01:35
Documents
92

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | POS AM | d184865dposam.htm iXBRL | POS AM | 2061043
2 | EX-23.1 | d184865dex231.htm | EX-23.1 | 1826
8 | GRAPHIC | g184865g00n05.jpg | GRAPHIC | 183233
9 | GRAPHIC | g184865g00n06.jpg | GRAPHIC | 142005
10 | GRAPHIC | g184865g07g07.jpg | GRAPHIC | 138066
11 | GRAPHIC | g184865g08g02.jpg | GRAPHIC | 69840
12 | GRAPHIC | g184865g08g03.jpg | GRAPHIC | 68913
13 | GRAPHIC | g184865g08g08.jpg | GRAPHIC | 138901
14 | GRAPHIC | g184865g09g01.jpg | GRAPHIC | 66771
15 | GRAPHIC | g184865g09g02.jpg | GRAPHIC | 61621
16 | GRAPHIC | g184865g10g40.jpg | GRAPHIC | 215067
17 | GRAPHIC | g184865g35j50.jpg | GRAPHIC | 31695
18 | GRAPHIC | g184865g96g96.jpg | GRAPHIC | 71058
| Complete submission text file | 0001193125-25-058954.txt |  | 9874508

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | okur-20241231.xsd | EX-101.SCH | 52302
4 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | okur-20241231_cal.xml | EX-101.CAL | 46848
5 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | okur-20241231_def.xml | EX-101.DEF | 273809
6 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | okur-20241231_lab.xml | EX-101.LAB | 430951
7 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | okur-20241231_pre.xml | EX-101.PRE | 378347
95 | EXTRACTED XBRL INSTANCE DOCUMENT | d184865dposam_htm.xml | XML | 689498

Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-282792 | Film No.: 25756367
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)